Visalytics
Visalytics
approved EB-2 (NIW)

Quality Control Analyst II

Vaccine Immunology · India · 2023-02-09

Processing Time
92 days
Decision Date
2023-02-09
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in vaccine development and clinical trial quality control, specifically focusing on how vaccine regimens affect the immune system and the mechanisms regulating vaccine protection. Her work aims to fundamentally transform vaccine development approaches for infectious diseases such as tuberculosis and HIV.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses pressing issues including the need for safe and effective vaccines for tuberculosis and HIV.

2 Well-positioned to Advance Endeavor Met

The petitioner has a strong background in vaccine regimens and has received funding from the NIH and the Bill and Melinda Gates Foundation.

3 Waiver of Job Offer/Labor Certification Met

On balance, her record of 483 citations and expertise in a critical health field makes her entry beneficial to the U.S. without a labor certification.

Why This Petition Was Approved

The petition was approved based on 3 peer-reviewed scientific articles in high-impact journals and a record of 483 citations from researchers in 41 countries. Additionally, she conducted 5 peer reviews for 3 journals and received funding from the National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation. Both NIW and EB1-A criteria were satisfied through her sustained national and international acclaim.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Pennsylvania 64 days 2025-11-26
The petitioner proposes to continue research on the fundamental mechanisms of cellular stress response and immune system function to advance vaccine development and biotherapeutics. The work utilizes antibody engineering and advanced sequencing technologies to create practical innovations for protecting vulnerable populations from respiratory infections. The intended impact is to address nationwide public health challenges and improve national health security through immediate therapeutic potential.
View Case

Postdoctoral Researcher

Biotechnology · Ethiopia

WeGreened EB-2 (NIW) approved
Tennessee 64 days 2025-03-13
The petitioner proposes to advance innovative immunization strategies and translational studies aimed at developing effective vaccines and therapeutics targeting infectious pathogens. The work focuses on investigating host-pathogen interactions and the underlying mechanisms of protective immune responses to strengthen public health systems.
View Case

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 30 days 2025-06-07
The petitioner proposes to develop and apply advanced immunological and virological methodologies to investigate viral persistence and immune response mechanisms. The work specifically focuses on chronic diseases such as HIV and Epstein-Barr Virus (EBV) to advance therapeutic strategies and vaccine development. This research aims to lower disease burdens and improve public health outcomes by addressing infectious disease control.
View Case

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
California 591 days 2025-11-27
The petitioner proposes to continue her research in biomedical science, specifically focusing on uncovering the mechanisms of disease-causing viruses and tuberculosis to identify how they operate and can be more effectively treated. Her work involves investigating viral mechanisms, immune responses, and therapeutic pathways to develop novel antiviral treatments and nonviral delivery platforms.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-09.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 92 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist